Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06718140

tFUS for Memory in mNCD and Healthy Adults

Personalized Transcranial Focused Ultrasound for Mild Neurocognitive Disorder and Healthy Aging

Status
Enrolling By Invitation
Phase
Phase 1
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Accepted

Summary

Dementia is an ongoing and growing public health crisis in the US and worldwide. The purpose of this study is to examine a form of noninvasive brain stimulation called transcranial focused ultrasound (tFUS) to the hippocampus with the goal of improving memory.

Detailed description

Dementia is an ongoing and growing public health crisis in the US and worldwide. Currently, there are an estimated 6.2 million Americans living with Alzheimer's Disease (AD) the most common form of dementia accounting for roughly 75% of cases. With a growing aging population, this number is estimated to be 13.8 million in the US and 152.8 million people worldwide by 2050 with a 14% lifetime prevalence. It is difficult to treat AD, making it critical to intervene as early as possible. Mild neurocognitive disorder (mNCD) is an early stage of memory and cognitive ability loss that is more severe than normal cognitive decline due to aging. Each year, approximately 15% of people with mNCD develop dementia, making it a critical juncture where intervention could be particularly impactful. Previous research has utilized a novel technique, called transcranial focused ultrasound (tFUS), to change brain function and has measured changes to brain activity through electroencephalography (EEG) using scalp electrodes. This study will apply tFUS to the hippocampus to examine the effects on memory in healthy adults in mNCD.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Focused UltrasoundUsing MRI-guided targeting, we will administer focused ultrasound to one of the 4 brain locations

Timeline

Start date
2025-03-30
Primary completion
2026-12-01
Completion
2027-12-01
First posted
2024-12-05
Last updated
2025-11-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06718140. Inclusion in this directory is not an endorsement.